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Naturally  occurring  feline  infectious  peritonitis  (FIP)  is usually  fatal,  giving  the impression
that  immunity  to the FIP  virus  (FIPV)  is extremely  poor.  This  impression  may  be incor-
rect,  because  not  all cats  experimentally  exposed  to FIPV  develop  FIP.  There  is  also  a  belief
that  the  incidence  of  FIP  may  be  affected  by  a number  of  host,  virus,  and  environmental
cofactors.  However,  the  contribution  of  these  cofactors  to immunity  and  disease  incidence
has not  been  determined.  The  present  study  followed  111  random-bred  speciﬁc  pathogen
free  (SPF)  cats  that  were  obtained  from  a single  research  breeding  colony  and  experimen-
tally  infected  with  FIPV.  The  cats were  from  several  studies  conducted  over  the  past  5  years,
and  as  a result,  some  of  them  had  prior  exposure  to feline  enteric  coronavirus  (FECV)  or
avirulent  FIPVs.  The  cats  were  housed  under  optimized  conditions  of  nutrition,  husbandry,
and  quarantine  to  eliminate  most  of  the  cofactors  implicated  in FIPV  infection  outcome  and
were  uniformly  challenge  exposed  to the same  ﬁeld  strain  of serotype  1 FIPV. Forty  of the
111 (36%)  cats  survived  their  initial  challenge  exposure  to a Type  I cat-passaged  ﬁeld  strains
of FIPV.  Six  of these  40 survivors  succumbed  to  FIP to  a second  or third  challenge  exposure,
suggesting  that  immunity  was  not  always  sustained.  Exposure  to  non-FIP-inducing  feline
coronaviruses  prior  to  challenge  with  virulent  FIPV  did  not  signiﬁcantly  affect FIP  incidence
but  did  accelerate  the  disease  course  in  some  cats.  There  were  no  signiﬁcant  differences  in
FIP  incidence  between  males  and  females,  but resistance  increased  signiﬁcantly  between
6 months  and  1  or more  years  of age.  Genetic  testing  was  done  on 107  of  the  111  infected
cats.  Multidimensional  scaling  (MDS)  segregated  the  107  cats  into  three  distinct  families
based primarily  on a common  sire(s),  and  resistant  and  susceptible  cats  were  equally  dis-
tributed within  each  family.  Genome-wide  association  studies  (GWAS)  on  73  cats  that died
of FIP  after  one  or more  exposures  (cases)  and  34 cats that  survived  (controls)  demonstrated
four  signiﬁcant  associations  after  100k permutations.  When  these  same  cats  were  analyzed
using a sib-pair  transmission  test,  three  of  the  four  associations  were  conﬁrmed  although
not with  genome-wide  signiﬁcance.  GWAS  was  then  done  on  three  different  age  groups  of
ccount  age-related  resistance,  and  different  associations  were  observed.cases  to take  into  a∗ Corresponding author. Tel.: +1 530 752 7402.
E-mail address: ncpedersen@ucdavis.edu (N.C. Pedersen).
http://dx.doi.org/10.1016/j.vetimm.2014.09.001
165-2427/© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/3.0/).
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The  only  common  and  strong  association  identiﬁed  between  the  various  GWAS  case  conﬁg-
urations  was  for the  34.7–45.8  Mb region  of  chromosome  A3.  No  obvious  candidate  genes
were present  in  this  region.
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1. Introduction
The prevalence and severity of infectious diseases
among multi-cat populations is a product of many
diverse factors that affect the host/pathogen interaction
(Pedersen, 1991). Environmental factors include things
such as population density, sanitation, and interchange
of animals while agent factors include virulence, dose,
and route of exposure. Host factors include developmen-
tal and heritable anomalies in the immune system and
age at the time of exposure and intercurrent illnesses.
Many of these diverse cofactors have been implicated in
FIP.
Foley et al. (1997) studied a number of environmental
risk factors for FIP in seven catteries and found that cat
numbers (density) and husbandry procedures had no inﬂu-
ence on FIP incidence while age, high coronavirus antibody
titers, and the proportion of cats shedding coronavirus
were signiﬁcantly associated with FIP risk. All of these risk
factors are interrelated, because fecal coronavirus shedders
are much more likely to have antibody titers >1:100 and
younger cats are more likely to shed FECV at higher lev-
els and for longer periods (Pedersen et al., 2004, 2008).
The stresses of placing young cats into shelters have also
been shown to greatly increase the levels of FECV shedding
(Pedersen et al., 2004).
Field strains of FIPV are known to vary intrinsically in
virulence and this virulence may  be further affected by the
route of administration (Pedersen et al., 1984; Pedersen
and Floyd, 1986). The dose of virus used also can alter dis-
ease outcome although a dose that causes lethal infection
in one cat may  be insufﬁcient to infect another (Pedersen
and Black, 1983). Virulence may  be inﬂuenced by the exact
FIP-inducing mutations that are present. The known FIP-
associated mutations in FECV 3c and the S1/S2 cleavage site
are highly variable and unique to each isolate while the two
single nucleotide mutations in the fusion domain are com-
mon  to all FIPVs (Pedersen, 2014). Mutations in 7b can also
alter virulence in some tissue culture-adapted strains, but
do not play a role in the FECV-to-FIPV mutations in nature
(Pedersen, 2014). Additional mutations may  await discov-
ery and their singular or collective roles in FIP remain to be
determined.
Several host factors have been implicated in FIP. The
stress of surgery, especially when performed at a young
age, may  increase susceptibility of cats to FIP development
(Kass and Dent, 1995). Co-infections with FeLV will greatly
increase the incidence of FIP by interfering with FIP immu-
nity; more than one-third of all FIP cases occurred in cats
that were persistently infected with FeLV (Cotter et al.,
1973; Pedersen et al., 1977). Feline immunodeﬁciency virus
(FIV) can also compromise host immunity and increase FIP
prevalence under experimental conditions (Poland et al.,
1996).lished  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
The present study was designed to eliminate as many
potential agents, environmental, and host risk factors for
FIPV infection as possible. The same ﬁeld strain and infec-
tious dose of virus were used for challenge exposure, a
uniform standard of care was  provided with no extrane-
ous pathogen exposure, and the cats originated from the
same breeding stock. The study was  then concentrated on
two  potential risk factors that have been poorly studied,
age at the time of exposure and genetic susceptibility.
The effect of age on FIPV infection has not been directly
addressed, even though it has been previously discussed
(Pedersen, 2009) and well documented for pathogens such
as feline leukemia virus (FeLV) (Hoover et al., 1976). Kit-
tens are born with immature immune systems, and the
period between 4 and 16 weeks of age is when IgG and
IgA systems are being compensated by passive local and
systemic immunity (Pedersen, 1987a). Immaturity of the
immune system may  also play a role in the ability to vac-
cinate kittens to FIP; a commercially marketed attenuated
live FIPV vaccine only demonstrated sufﬁcient efﬁcacy for
licensing when given to kittens 16 weeks or older (Gerber
et al., 1990). Field and laboratory studies indicate that some
sort of maternal or innate resistance to FECV infection is
present in neonatal kittens and that FECV fecal shedding
usually does not occur until 9 weeks of age, even among kit-
tens born to infected queens (Pedersen et al., 2008). Most
cases of FIP occur in cats between 4 and 18 months of age
(reviewed Pedersen, 2009) suggesting that some infections
may  remain subclinical for an extended period of time.
The possible role of genetics in FIP resistance has been
implied from a number of studies. FIP did not exist before
the 1950s (Holzworth, 1963), suggesting that cats may  not
have had time to genetically adapt, thus explaining why
morbidity and mortality are so high in experimental FIPV
infections. Pedigreed cats are more likely to develop FIP
than random-bred cats (Robison et al., 1971; Rohrbach
et al., 2001; Pesteanu-Somogyi et al., 2006; Worthing et al.,
2012), and certain breeds are also more likely to succumb to
FIP (Bell et al., 2006; Norris et al., 2005; Pesteanu-Somogyi
et al., 2006; Worthing et al., 2012). One study of Persian cat-
teries and pedigrees indicated that susceptibility to FIP was
at least 50% heritable (Foley and Pedersen, 1996). Resis-
tance to FIP in Birman cats also appears to have a genetic
component as determined by GWAS (Golovko et al., 2013).
Natural resistance to FIP has also been observed in up to
one-third of random-bred cats used as controls in vac-
cine studies (Baldwin and Scott, 1997; Gerber et al., 1990;
Glansbeek et al., 2002; Hohdatsu et al., 2003; Kiss et al.,
2004; Pedersen and Black, 1983; Wasmoen et al., 1995).
The cats, infection outcome data, and DNA used in the
present study originated from studies on type 1 FIPV and
FECV conducted over the last several years with other
objectives. Over the course of these studies, 111 cats of
various age and gender were exposed one or more times
logy an
t
m
o
r
w
f
f
a
f
a
s
o
2
2
b
t
I
a
s
t
d
d
r
r
R
H
t
n
e
m
I
#
2
2
p
p
o
e
(
o
a
2
i
0
a
a
d
d
m
eN.C. Pedersen et al. / Veterinary Immuno
o virulent strains of FIPV and their disease course closely
onitored and cause of death conﬁrmed to be FIP. Forty
f the 111 cats resisted a single challenge exposure and 34
emained resistant after repeated infections. The studies
ere unique in that all of the cats were housed in identical
acilities, cared for in an identical manner, and maintained
ree from other feline pathogens. Therefore, they were not
ffected by many of the agents, environmental, and host
actors that might affect the incidence of FIP in nature. This
llowed for an uncomplicated assessment of risk factors
uch as age, gender, and genetic susceptibility on disease
utcome.
. Materials and methods
.1. Experimental animals
Cats were obtained from the speciﬁc pathogen free (SPF)
reeding colony of the Feline Nutrition and Pet Care Cen-
er, University of California, Davis (UC Davis) (UC Davis
ACUC #16988). The colony was established in 1976 with
 small number of cats derived aseptically by cesarean
ection and records on all matings have been maintained
o the present time. Mating pairs were selected based on
egree of relatedness and outcrossing to enhance genetic
iversity done on two occasions, 1995 and 1999. The
elationships of all cats were known from the colony
ecords.
Cats used for this study were housed in the Feline
esearch Laboratory of the Center for Companion Animal
ealth under conditions required by USDA regula-
ions. Fifty-four of the 111 of cats were coronavirus
aïve while 57 had previous FECV or non-virulent FIPV
xposure (Pedersen et al., 2008, 2009, 2012). Experi-
ental infection studies were conducted under UC Davis
nstitutional Animal Care and Use Committee protocol
16637.
.2. Experimental infection studies
.2.1. FIPV infection
The origins of Type I FIPV-i3c2 and FIPV–m3c2 and the
reparation of cell-free infectious inoculates have been
reviously described (Pedersen et al., 2012). A total of 1 ml
f a 1:5–1:10 dilution of a 25% cell-free suspension of dis-
ased omentum was given by either the intraperitoneal
IP) or oronasal (ON) route. This proved infectious to 100%
f cats by either route based on the occurrence of disease
nd/or seroconversion.
.2.2. Inoculation procedures and disease monitoring
Cats were sedated with ketamine hydrochloride and
noculated either intraperitoneally (IP) or ON (0.5 ml  orally,
.5 ml  nasally) with the various virus stocks. Rectal temper-
tures were recorded starting 1–2 days prior to inoculation
nd at 1–2 day intervals thereafter. Cats were examined
aily for signs of disease, such as fever, inappetance,
epression, diarrhea, dehydration, ascites, hyperbilrubine-
ia, hyperbilirubinuria, and jaundice. Affected cats were
uthanized with an intravenous overdose of pentabarbital/d Immunopathology 162 (2014) 33–40 35
phenytoin as soon as their disease course was  deemed
terminal.
2.3. Feline coronavirus serology
Antibodies to feline coronavirus were titrated by
indirect immunoﬂuorescence using Crandell-Rees feline
kidney cells infected with FIPV-79-1146 as an antigen sub-
strate (Pedersen, 1976).
2.4. Genetic testing
Whole EDTA-treated blood was  available from 107 of
111 cats and genomic DNA isolated using the Qiagen
(Valencia, CA) Gentra Puregene Blood Core Kit. GWAS was
performed using the Illumina Inﬁnium iSelect feline DNA
array (Illumina Inc., San Diego, CA). The arrays were tested
by GeneSeek Inc. (Lincoln, NE). SNP genotyping rate and
minor allele frequency (MAF) was  evaluated using PLINK
(Purcell et al., 2007). SNPs with a MAF  < 5%, genotyping
rate < 90%, and individuals genotyped for <90% of SNPs
were excluded from downstream analyses.
An MDS  with two dimensions was performed on 41,004
SNPs in PLINK to evaluate population substructure within
cases and controls. Inﬂation of p-values was evaluated by
calculating the , and assessed with a Q–Q plot. A case-
control whole genome association analysis was performed
and corrected with 100,000 t-max permutations (-mperm
100,000) with signiﬁcance at −log10 (Pgenome) ≥ 1.3.
The transmission disequilibrium test among sib-pairs
(sib-TDT) (Spielman and Ewens, 1998) was performed
on 18 phenotypically discordant sib-pairs using the
function (–dfam). The sib-TDT analysis was  conducted
without including the founders in frequency calculation
(–nonfounders).
3. Results
3.1. Infection and immunity studies
One hundred eleven cats were experimentally infected
with virulent FIPV either by the IP or ON routes, and the dis-
ease outcome ultimately conﬁrmed either by necropsy or
seroconversion. There was no difference in challenge out-
come between the two routes (data not shown). Fifty-seven
cats had one or two prior exposures to FECV, non-infectious
FIPV mutants, or sub-infectious doses of virulent FIPV.
Thirty-three of these 57 (58%) cats developed fatal FIP, com-
pared to 38 of 54 (70%) of naïve cats after experimental
infection with virulent FIPV (Fig. 1), which was not signiﬁ-
cantly different (p = 0.24, Fisher’s exact test).
The strength of immunity was tested by re-challenge.
Twenty two of 24 (92%) of the pre-sensitized survivors and
14 of 16 (88%) survivors without prior coronavirus expo-
sure were still resistant after a second challenge-exposure
(Fig. 1). Thirteen survivors from both groups were then
exposed to FIPV a third time, and 11 of 13 (85%) remained
resistant (Fig. 1). One cat survived a fourth infection and
another survived ﬁve exposures (Fig. 1).
The onset of disease after FIPV infection always coin-
cided with the appearance of fever (Fig. 2), which
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Fig. 1. Outcome of FIPV challenge-exposure in naive or feline coronavirus
pre-sensitized cats. Control cats resisted disease.
Fig. 2. The temperature proﬁle of cats after infection with virulent FIPV for
the  ﬁrst time. Solid ﬁlled square represents the average temperature with
Fig. 4. The effect of age at the time of exposure on FIP incidence.standard deviation of 40 cats that did not develop FIP after primary infec-
tion. The open symbols with dashed lines are representative of individual
FIP  cat.
was rapidly followed by other signs such as inappe-
tence, lethargy, cessation of grooming, hyperbilirubinemia,
hyperbilirubinuria, jaundice, and ascites. In contrast, cats
that resisted disease showed virtually no febrile response,
remained outwardly normal, and seroconverted (Fig. 2).
Pre-sensitization to non-disease-causing feline coro-
naviruses did not signiﬁcantly alter the mortality rate
although cats with prior exposure were somewhat more
likely to develop accelerated disease (Fig. 3). All of the
Fig. 3. Survival of FIP cats after FIPV challenge exposure. Cats were pre-
sensitized to feline coronavirus by prior exposure to FECV, non-infectious
FIPVs or sub-infectious dose of FIPV (- - - -), or had no prior feline corona-
virus exposure ( ).Fig. 5. Manhattan plot comparing 73 cats that died of FIP and 34 cats that
survived.
cats with prior coronavirus exposure became terminally
ill within 31 days while ﬁve cats without prior exposure
survived from 33 to 105 days. Four of these ﬁve slow pro-
gressors died of non-effusive of FIP and one of effusive FIP.
Survival rates were examined for cats of different gen-
der and age. No difference was  observed in FIP incidence
between male and female cats (data not shown). There was
a progressive and signiﬁcant (p = 0.0008) decrease in mor-
tality from 6 months to greater than 1 year of age (Fig. 4).
Over 80% of cats younger than 6 months of age died com-
pared to less than 45% of cats infected at greater than 1 year
of age. Cats from 6–12 months of age were intermediate in
susceptibility.
FIP is known to persist in a subclinical form for some
period of time following survival from challenge exposure
to FIPV (Pedersen, 1987b) and this has confounded the
interpretation of survival data in past FIP vaccine studies
(Baldwin and Scott, 1997; Hoskins et al., 1994). To rule out
subclinical infections among resistant cats in the present
study, six individuals that had survived two  or more chal-
lenge exposures were necropsied after 4–6 months and
examined for subclinical lesions. No gross evidence of
subclinical disease was found. Therefore, most cats that
survived FIPV challenge will eventually clear the infection
if given enough time.
3.2. Genetic analysesGenome-wide association studies were conducted on
107 of the 111 infected, including 73 cases and 34 controls.
PLINK analysis showed SNPs with genome-wide signiﬁ-
cance on chromosomes A3, B1, B4, and C1 (Fig. 5). A ﬁfth
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Fig. 6. MDS  plot of the 107 cats in the study based on PLINK analysis
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Fig. 8. GWAS done on three groups of case and control cats based on age
of  cases (died FIP) at the time of exposure. (a) 34 cases and 34 controlsf GWAS data. Cats dying of FIP (©) or surviving challenge exposure ()
ere segregated among three families. Family A had multiple related sires
hile families B and C were each derived from a single sire.
NP with genome-wide signiﬁcance was present among
on-annotated SNPs (UK) but was not further investigated.
In order to determine any effect of relatedness on GWAS
f the total population, family-related substructure was
etermined by multidimensional scaling (MDS). MDS seg-
egated all case and control cats into three separate families
A, B, C) (Fig. 6). Cats from family A were sired by multi-
le related cats while cats in families B and C were each
escended from a single sire. There was no signiﬁcant dif-
erence in how FIP resistant and susceptible cats segregated
etween and within families (Fig. 6).
The family substructure identiﬁed by MDS  was
mended using a sib-TDT analysis with 18 phenotypically
iscordant nuclear families. After permutation, none of the
NPs remained genome-wide signiﬁcant although strong
ssociations were again observed on chromosomes A3, B1,
nd C1, the association on B4 was lost, and two new asso-
iations occurred on chromosomes C2 and D3 (Fig. 7).
It was apparent that age at the time of exposure was
 signiﬁcant independent risk factor for disease outcome.
herefore, an attempt was made to compensate for age in
he selection of cats used for GWAS (Fig. 8). The control
roup of cats remained the same based on the assump-
ion that if a cat survived FIPV infection at <6 months of
ge, it would also survive exposure at 6 months and older.
onversely, a cat that died when exposed at <6 months of
ge might have survived if infected at >6 months of age
ig. 7. Sib-transmission/disequilibrium test of 54 cats that died of FIP
nd 24 survivors using the –dfam and 100,000 permutation command in
LINK. Five peaks of strong association were identiﬁed on deﬁned chromo-
omes. Four of the ﬁve associations were near potential candidate genes
elevant to FIP immunopathogenesis.(resistant) cats <6 months of age; (b) 27 cases and 34 controls >6 months
and  <1 year of age at time of exposure; (c) 39 cases and 34 controls that
are all >6 months of age at time of exposure.
independent on any genetic factors. Although the popu-
lation size of case and controls was  similar for each age
group tested by GWAS, there were marked differences in
the major genome-wide associations seen on Manhattan
plots depending on the age of the case cats at the time
of FIPV exposure (Fig. 8). The only strong association in
common with these three age-adjusted GWAS studies and
the total case/control population was  for a region on chro-
mosome A3 that extended from 34.7–45.8 Mb  (Table 1). It
was also noteworthy that a disproportionate number of the
highest 25 ranking SNPs fell into this region, regardless of
the conﬁguration of case and controls based on age (Fig. 8),
relatedness (Fig. 7), or on neither of these factors (Fig. 6).
Based on Ensembl, this region contains 41 protein-coding
genes and 9 novel protein-coding transcripts. None of the
41 genes appeared to be obvious candidates for immune or
inﬂammatory processes involved in FIP.
4. Discussion
The goal of this study was to identify cofactors that
were most strongly involved with natural resistance to
FIPV infection. This was  accomplished by negating as
many potential cofactors as possible using a standardized
virus challenge, cats from the breeding facility, opti-
mal  husbandry, providing a uniform environment and
diet, minimizing extraneous stresses, and eliminating the
effects of other common infections that might occur in
multi-cat environments such as catteries or shelters. After
minimizing the agent, environmental, and host cofactors,
the opportunity existed to study host-related factors such
as genetics, age, and gender on FIP resistance.
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Table  1
SNPs on chromosome A3 that were ranked among the top 25 in GWAS comparing all case and controls, family-adjusted case and controls, and age-adjusted
case  and controls.
SNP bp 73FIP/34C
(All)
53FIP/24C
(Family)
34FIP/34C
(<6 month)
27FIP/34C
(6 month–1year)
39FIP/34C
(>6 month)
chrA3.3103603 25933838 0.045
chrA3.40285519 34704954 0.032
chrA3.40449694 34833752 0.005 0.034 0.15
chrA3.41176774 35406318 0.002 0.026 0.006 0.023
chrA3.44853345 38346280 0.057
chrA3.45799457 39123818 0.049
chrA3.47421518 40516688 0.134
chrA3.54308442 45779892 0.018 0.099
chrA3.74920495 57890498 0.054 0.159
chrA3.43254032 98000766 0.32
chrA3.41399492 114615800 0.47
chrA3.41996044 147847406 0.27
The present study also dealt with the strength of immu-
nity, which does not appear to be absolute. About 10% of
cats that survived one FIPV infection succumbed to a sec-
ond or third exposure. A similar occurrence was  observed
by Wasmoen et al. (1995); one of ﬁve cats that had suc-
cessfully resisted a challenge exposure that killed 4 of 5
non-vaccinates developed FIP upon a second exposure.
This type of immunity is different from that established
by feline panleukopenia, a parvovirus disease. Panleukope-
nia immunity is usually solid and is more dependent on
humoral than cellular responses (Scott, 1987). Therefore,
FIPV immunity more closely resembles immunity to its par-
ent virus, feline enteric coronavirus (FECV). FECV-infected
cats shed virus in their feces for weeks or months before
sufﬁcient immunity develops to stop shedding, but after
shedding ceases, antibody levels fall and many of the cats
become susceptible to reinfection (Pedersen et al., 2008).
Subclinical disease is also known to linger after initial
natural and experimental infection in some cats as demon-
strated by FeLV activation (Pedersen, 1987b; Pedersen
et al., 1977).
This was the ﬁrst study documenting the signiﬁcance of
age at time of exposure on FIPV outcome, even though it
has been frequently cited as a disease cofactor (Pedersen,
2009). Immunity to experimental FIPV infection increased
progressively from 4 months of age through adulthood.
Gerber et al. (1990) also reported an age-related response
to an attenuated live FIPV vaccine, with signiﬁcant pro-
tection only observed when vaccination was started at
16 weeks of age. The effect of age on disease outcome is
well known for infectious disease agents such as feline
leukemia virus (Hoover et al., 1976). Age resistance to FeLV
increases dramatically during kittenhood as the immune
system matures and has confounded FeLV vaccine duration
of immunity studies (Wilson et al., 2012).
Gender, in particular intact males, has been reported as
a risk factor for FIP in other studies (Norris et al., 2005;
Pesteanu-Somogyi et al., 2006; Rohrbach et al., 2001). We
did not see a gender bias in the present study, nor was it
seen in an earlier study of purebred and random-bred cats
(Foley et al., 1997).
A large component of the present study involved
attempts to associate FIP resistance to speciﬁc genetic
markers by GWAS. Previous experience with a large cohortof inbred Birman cats (Golovko et al., 2013) suggested
that this approach could be applied to the present cohort
of randomly bred cats. However, the same population
substructure problems encountered in the Birman study
were faced in this study. GWAS comparing all cases
and controls demonstrated four signiﬁcant genome-wide
associations on several chromosomes and some possible
candidate genes. However, there was  considerable popu-
lation substructure as revealed by MDS  and attributed to
separate male founder effects. Population substructure due
to relatedness in a case-control study can be overcome
by using different types of analysis, such as the trans-
mission disequilibrium test (TDT) or the sib-TDT that was
employed in this study. A previous GWAS study localized
the autosomal recessive locus associated with hypokalemia
in cats by analyzing as few as 35 cases and 25 con-
trols (Gandolﬁ et al., 2012). However, the present study
was  conducted on random-bred cats, which are known
to have less linkage disequilibrium than within pedigreed
cats (Alhaddad et al., 2013). The study was  further con-
founded by the polygenic appearance of the inheritance.
Inheritance to FIP resistance/susceptibility in a similarly
sized cohort of Birman cats also appeared to be poly-
genic and there were no common regions of association,
which would have reinforced both studies (Golovko et al.,
2013).
To compensate for family-related substructure, a
transmission disequilibrium test among sib-pairs using
the statistics of Spielman and Ewens (1998) was then
performed. Eighteen discordant sib-pair nuclear fami-
lies were identiﬁed within the cohort, which was  more
than the 13 phenotypically discordant sib-pairs that
successfully detected the association with a cone-rod
dystrophy in dogs (Wiik et al., 2008). Based on sib-TDT on
the FIP cohort, ﬁve strong SNP associations on different
chromosomes were identiﬁed, but none reached genome-
wide signiﬁcance. SNPs on chromosomes A3, B1, and C1
were shared by the two  different analyses while two
new associations on chromosomes C2 and D3 appeared.
Although the associations detected by sib-TDT did not
reach genome-wide signiﬁcance after permutations,
similar regions were suggested by both analyses within
the three overlapping chromosomes. It is possible that
these regions could reach genome-wide signiﬁcance if
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ore discordant sib-pairs are added to the association
nalysis.
An attempt was also made to compensate for age at
he time of exposure as an independent and presumably
on-genetic risk factor for FIP resistance. Unfortunately,
he number of case and control cats challenge exposed
fter 1 year of age was too low, so cats exposed at >6
onths and >1year were combined. The control popula-
ion remained the same for all GWAS conﬁgurations based
n the premise that kittens surviving exposure at less than
 months of age would still resist exposure as they aged. As
as expected based on previous GWAS conﬁgurations, rel-
tively small changes in the case populations had a marked
ffect on observed associations. After comparing the results
f GWAS based on age, GWAS of the total population,
nd GWAS based on family structure, only one peak of
trong, but not genome-wide signiﬁcant, associations were
resent on chromosomes A3 in a region between 34.8 and
6 Mb.  Thirty ﬁve annotated genes were present within this
egion, but none appeared to be strong candidates for FIP
esistance.
It can be concluded from these various GWAS stud-
es that resistance to FIP in this population of relatively
andom-bred SPF cats was not inﬂuenced by a single or
ven small number of genes. As in an earlier study with
 much more inbred Birman population (Golovko et al.,
013), any genetic component of resistance is likely to
e polygenic and divergent between various populations.
lthough mutations in a single gene have been identiﬁed
hat confer resistance to infectious disease, such as the
CR5 mutation for HIV infection (Dean et al., 1996), suscep-
ibility and resistances to infectious agents clearly involve
omplex host/virus/environment interactions that make
enetic studies difﬁcult. This has been shown in diseases
uch as human and ruminant tuberculosis (Chimusa et al.,
014; le Roex et al., 2013), a disease that closely resembles
he dry form of FIP. The existence of additional risk factors,
nvolving the environment, host, and agent, is perhaps one
f the most daunting problems in the search for genetic
nﬂuences on infectious diseases. This study removed a
arge number of those confounding factors but was  still
nable to identify speciﬁc genes that might be involved
n FIP resistance. Unfortunately, even highly inbred breeds,
uch as Birman, with signiﬁcant linkage disequilibrium and
losed colonies, such as the one in this study, suffer from
igh genomic inﬂations. Even so, the strong associations
emonstrated in this relatively small GWAS employing a
elatively low-density array indicate that FIP resistance is
nﬂuenced in some part to genetic factors. The heritabil-
ty of these genetic factors remains a subject of ongoing
reeding studies.
We  did not interrogate one region on chromosome
3 that was consistently found to differ in association
etween all of the various GWAS conﬁgurations. Hope-
ully, the present data can be reanalyzed as the cat genome
nnotation improves and more dense arrays become
vailable. Next-generation and whole exome sequencing
re also becoming cost accessible and might be prefer-
ble ways to search for complex genetic associations
nd speciﬁc mutations. It might also be fruitful to mate
mmune cats to see if resistance is heritable and if so,d Immunopathology 162 (2014) 33–40 39
to do GWAS or next-generation sequencing on their
offspring.
5. Conclusion
The objective of this study was to deﬁne natural immu-
nity to FIP among randomly bred speciﬁc pathogen-free
cats bred for laboratory purposes under conditions that
would eliminate as many extrinsic disease cofactors as pos-
sible. Cats were housed free of other feline pathogens and
fed and cared for in a uniform manner. This emphasized the
relative inﬂuence of age at the time of exposure, strength of
immunity as gauged by repeated challenge exposure, and
possible genetic resistance. One-third of random-bred lab-
oratory cats used in various studies over the last decade
appeared to be resistant to infection with Type I ﬁeld strains
of FIPV. However, immunity was not absolute and a small
number of cats died after a second and even third chal-
lenge. Age at the time of exposure seemed to be the most
signiﬁcant predictor of resistance; cats under 6 months
of age were most apt to develop FIP, cats 6–12 months
were intermediate, and cats over 12 months of age demon-
strated signiﬁcant resistance. Strong genetic associations
were identiﬁed by GWAS in regions of several chromo-
somes, especially when comparing all cats that died of FIP
with all survivors. However, all but one of these regional
associations changed when GWAS was  adjusted for family
substructure or age at the time of FIPV exposure. This con-
ﬁrmed previous GWAS studies on FIP resistance in Birman
cats (Golovko et al., 2013); both studies showed inheritance
of FIP resistance to be highly complex and confounded
by considerable population stratiﬁcation. Future breeding
studies will hopefully conﬁrm the heritability of FIP resis-
tance.
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